MADCAM1 (mucosal vascular addressin cell adhesion molecule 1)

2016-08-01  

Identity

HGNC
LOCATION
19p13.3
LOCUSID
ALIAS
MACAM1
FUSION GENES

Other Information

Locus ID:

NCBI: 8174
MIM: 102670
HGNC: 6765
Ensembl: ENSG00000099866

Variants:

dbSNP: 8174
ClinVar: 8174
TCGA: ENSG00000099866
COSMIC: MADCAM1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000099866ENST00000215637Q13477
ENSG00000099866ENST00000346144Q13477
ENSG00000099866ENST00000382683Q13477
ENSG00000099866ENST00000587541U3KQ59
ENSG00000099866ENST00000613880A0A087WXC9
ENSG00000099866ENST00000617201A0A087X1M5
ENSG00000099866ENST00000619333A0A087X1F1
ENSG00000099866ENST00000621286A0A087X0U8
ENSG00000099866ENST00000622462A0A087WWC0

Expression (GTEx)

0
1
2
3
4
5
6
7
8
9

Pathways

PathwaySourceExternal ID
Cell adhesion molecules (CAMs)KEGGko04514
Cell adhesion molecules (CAMs)KEGGhsa04514
Intestinal immune network for IgA productionKEGGko04672
Intestinal immune network for IgA productionKEGGhsa04672
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellREACTOMER-HSA-198933
Extracellular matrix organizationREACTOMER-HSA-1474244
Integrin cell surface interactionsREACTOMER-HSA-216083

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
338285602021Frequency of Effector Memory Cells Expressing Integrin α(4)β(7) Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4(+) T Cell Count.4
341944202021sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.4
338285602021Frequency of Effector Memory Cells Expressing Integrin α(4)β(7) Is Associated With TGF-β1 Levels in Therapy Naïve HIV Infected Women With Low CD4(+) T Cell Count.4
341944202021sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection.4
322932992020Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.7
322932992020Baseline levels of dynamic CD4(+) T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study.7
318666202019Expression of mucosal addressin cell adhesion molecule-1 on the reticular framework between white pulp and the marginal zone in the human spleen.1
318666202019Expression of mucosal addressin cell adhesion molecule-1 on the reticular framework between white pulp and the marginal zone in the human spleen.1
259085212016Development and validation of receptor occupancy pharmacodynamic assays used in the clinical development of the monoclonal antibody vedolizumab.10
259085212016Development and validation of receptor occupancy pharmacodynamic assays used in the clinical development of the monoclonal antibody vedolizumab.10
261241822015Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.10
261241822015Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells.10
232974162013Domain 1 of mucosal addressin cell adhesion molecule has an I1-set fold and a flexible integrin-binding loop.6
238393402013Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates.6
232974162013Domain 1 of mucosal addressin cell adhesion molecule has an I1-set fold and a flexible integrin-binding loop.6

Citation

Dessen P

MADCAM1 (mucosal vascular addressin cell adhesion molecule 1)

Atlas Genet Cytogenet Oncol Haematol. 2016-08-01

Online version: http://atlasgeneticsoncology.org/gene/55892